Introduction
Zika virus (ZIKV) is a mosquitotransmitted flavivirus, recently linked to microcephaly following a maternal infection during pregnancy. 1 Vertical transmission of ZIKV has been associated with fetal microcephaly and development of the congenital ZIKV syndrome, a condition encompassing a spectrum of fetal neurologic injury including cortical malformations, ventriculomegaly, ocular injury, and arthrogryposis. [2] [3] [4] A maternal ZIKV infection has been associated with a rate of birth defects between 5e8%, but may be as high as 13% when infection occurs in the first trimester. 5, 6 Recently, reports of children with a normal head circumference (HC) at birth who were later found to have abnormal brain imaging, ocular injury, and postnatal development of microcephaly, has led to the concept that microcephaly does not capture the broader spectrum of ZIKVassociated brain injury. 3, [7] [8] [9] [10] Identification of fetuses with a normal head size that are at risk for long-term adverse outcomes remains limited due to the incomplete knowledge of how a less overt spectrum of ZIKV-associated fetal injury may be detected prenatally. This limitation is further compounded by weaknesses related to diagnostic testing including: (1) inadequate availability of ZIKV testing in regions at risk, (2) lower sensitivity of real-time polymerase chain reaction testing due to the transient nature of ZIKV viremia, and (3) lower positive predictive value of serologic testing due to cross-reactivity between ZIKV and related flaviviruses.
In a nonhuman primate model, ZIKV-associated fetal brain injury was associated with an unusual femursparing profile of intrauterine growth restriction (IUGR) notable for a growth arrest in ultrasound biometric measures of the fetal head (biparietal diameter [BPD] ) and abdomen (abdominal circumference [AC] ) with continued growth of the femur (femur length [FL] ). 11, 12 This profile of IUGR has been noted as "femur-sparing," 13 but has not been characterized in a clinical study nor is it part of the mainstream categories for IUGR; typically, IUGR has been defined as asymmetric (conserved head growth with lagging growth of the abdomen) or symmetric (equal growth restriction of the head, abdomen, and femur). 14 There is a paucity of data to link aberrant fetal growth in the context of a maternal ZIKV infection to long-term adverse outcomes in the neonate, but IUGR may represent a sensitive indicator of viral injury to the placenta or fetus itself. Whether fetuses exposed to ZIKV with abnormal growth patterns, without microcephaly, may be more susceptible to eye injury or late-onset microcephaly is unknown and represents an important knowledge gap. 15 Although IUGR has been reported in pregnant women with a possible ZIKV infection, the profile of IUGR has not been described. 2, 10 Our objective was to determine if maternal ZIKV infection was associated with a femur-sparing profile of growth restriction, similar to observations in a nonhuman primate model of congenital ZIKV infection. 11, 12 Such an observation may be a first step in identifying nonmicrocephalic fetuses at risk for longterm morbidity.
Materials and Methods

Study population and ethics statement
All pregnant women presenting to Columbia University Medical Center from Jan. 1, 2016, through Feb. 1, 2017, from an area with known ZIKV local transmission were offered screening per Centers for Disease Control and Prevention (CDC) recommendations. The Columbia University Institutional Review Board approved the study (IRB-AAAQ9686) as a retrospective chart review and informed consent was not required. Cases were excluded if no ultrasound for fetal size or anatomy was completed prior to delivery. The gestational age and due date were estimated according to methods recommended by the American Congress of Obstetricians and Gynecologists. 16 Following ZIKV diagnosis, a pregnancy ultrasound was performed, and repeated every 3e4 weeks, for the duration of the pregnancy. Timing of ZIKV exposure was estimated based on maternal travel history, but could have occurred later in pregnancy due to sexual exposure from an infected partner; therefore, we included 4 subjects with immediate preconception exposure. Neonatal outcomes were assessed through measurement of a postnatal HC and head ultrasound scan in the first week of life. A more comprehensive assessment of outcomes was not possible due to limitations on our institutional human subject's approval and the challenge of data procurement from multiple private pediatric clinics in New York, NY; therefore, results for some recommended neonatal screening tests were not obtained.
ZIKV diagnosis
Based on uncertainties in the diagnostic testing for ZIKV infection, we followed CDC convention to describe women as having a "possible" ZIKV infection based on: (1) ZIKV infection detected by RNA testing on maternal, placental, or fetal specimen; or (2) diagnosis of ZIKV infection or unspecified flavivirus infection, timing of infection cannot be determined (ie, positive/equivocal ZIKV IgM and ZIKV plaque reduction neutralization test [PRNT] titer !10, regardless of dengue virus PRNT value; or negative ZIKV IgM, and positive or equivocal dengue virus IgM, and ZIKV PRNT titer !10, regardless of dengue virus PRNT titer). 17, 18 We also followed CDC guidance for the interpretation of laboratory testing of the infant for evidence of congenital ZIKV infection. 17 
AJOG at a Glance
Why was this study conducted? To determine if Zika virus infection during pregnancy is associated with a femursparing pattern of fetal growth restriction, similar to observations in a nonhuman primate model of decelerating growth of the fetal head and abdomen with respect to femur length.
Any positive nucleic acid test from a serum, urine, or cerebrospinal fluid sample was considered a confirmed congenital ZIKV infection. Any nonnegative IgM result (eg, positive, equivocal) from infant serum with a negative nucleic acid test was considered a probable congenital ZIKV infection.
Ultrasound methodology
The 2014 International Fetal and Newborn Growth Consortium for the 21st Century Project (IG-21) sonographic standard was used to derive Z-scores for HC, AC, and FL, as well as ratios for HC:FL and AC:FL. [19] [20] [21] Ultrasound scans were originally performed using Hadlock methodology, which measures BPD in a cross-section view from outer-to-inner skull edges. As IG-21 measures the BPD from outer-toouter skull edges, BPD measurements in this study were not directly translatable to the IG-21 sonographic standard. We chose instead to focus the analysis on HC, AC, and FL measurements from which we could directly calculate Z-scores. As the sonographic standard or reference used to interpret fetal size is expected to influence detection of IUGR in pregnancies with maternal ZIKV infection, we also corroborated the findings by applying references from the World Health Organization (WHO)-sponsored Fetal Growth Chart study (WHO-FGC). 19, 22 Online calculators were used to obtain Z-scores for IG-21 21 and published charts allowed estimation of percentiles for WHO-FGC. 19, 22 Notably, the WHO recommends that diagnosis of ZIKVassociated microcephaly use the IG-21 standard when the gestational age is accurately known and WHO-FGC when gestational age is not reliably known. 23 Studies of pregnancy outcomes from Brazilian women with ZIKV infection have also used the IG-21 standard to determine distribution of fetal biometric measures. 9, 24, 25 We did not evaluate our data based on sonographic standards developed in the United States for 2 reasons. First, the 1983 Hadlock standard (N ¼ 392) was based on a relatively small cohort of white women and has anecdotally been associated with a common diagnosis of "short femur." [26] [27] [28] [29] Second, application of racial/ethnic specific standards based on the Eunice Kennedy Shriver National Institute of Child Health and Human Development Fetal Growth Study (N ¼ 2334) 30 would only have allowed for assignment of biometric measures within ranges of centiles (ie, <3rd, 3rde5th, 5the10th), but not a more precise and quantitative analysis necessary to test our hypothesis. Our data on subject ethnicity were also incomplete. We ultimately chose to compare our data to the IG-21 and WHO-FGC standards as they were large population-based studies from multiple countries that included an ethnically diverse cohort. Notably, we could also use the IG-21 standard to specifically test our hypothesis of a femur-sparing profile of fetal growth restriction using fetal body ratios.
Definitions for microcephaly and IUGR
Variations in the definition for prenatal diagnosis of microcephaly with possible ZIKV infection exist among guidelines and standards. 10, 24, 31 The International Society of Ultrasound in Obstetrics and Gynecology recommends heightened surveillance with specialist referral and neurosonography for fetuses with a HC <2 SD below the mean (Z-score e2 SD). 32 The WHO definition for fetal microcephaly, in the context of ZIKV infection, is a HC e2 SD below the mean. 24 After birth, the CDC definition for microcephaly is a HC <3rd centile for gestational age in the setting of congenital ZIKV exposure ( e2 SD).
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Based on this guidance, we defined microcephaly in our study as a fetal HC Z-score e2 (2.3%, IG-21) or <3rd centile (WHO-FGC).
There is no gold standard to define IUGR and it has been variably defined by deviation of fetal size from a normal distribution at either the 10th, 5th, or 3rd centile.
34, 35 The estimated fetal weight (EFW) and AC are consistently identified as important parameters in making the diagnosis and a typical threshold is <10th centile; however, this definition will include many constitutionally small fetuses and miss growth-restricted fetuses that are >10 th centile. 36 In this study, we present results using both a conservative (AC <3%, wZ-score e2) and traditional (AC <10%, wZ-score e1.3) definition for IUGR to allow comparison of results with AC:FL, a fetal body ratio for AC normalized to FL. Due to the difference in BPD measurements between Hadlock and IG-21, BPD could not be used to calculate EFW; therefore, EFW was not used as a measure of IUGR in this study.
Estimating population distribution of fetal body ratios
Fetal body ratios normalized to FL were hypothesized to represent a more sensitive method to detect aberrant growth patterns in fetuses with congenital ZIKV exposure. This approach has the advantage of directly addressing our hypothesis by comparing the size of fetal structures (ie, head, abdomen) to FL for each fetus, but may not detect constitutionally small fetuses and fetuses with symmetric IUGR. The WHO-FGC has published ratios for FL:HC, but values often overlapped several strata making it difficult to categorize some cases into discrete strata. 19 Therefore, we focused attention on the IG-21 standard from which we could calculate Z-scores for HC:FL and AC:FL.
Published thresholds for IG-21 body ratios did not exist; therefore, we developed these formulas, including mean and SD from the original data (means and SD by gestational week shown in Supplemental Tables 1-3) . Statistical methods used to construct the fetal biometry ratios were selected using a previously published strategy. 20, 37 In brief, fractional polynomial regression was used, and the resulting functional form further modelled in a multilevel framework to account for the longitudinal design of the study. Goodness-offit was evaluated with visual inspection of overall model fit using quantilequantile plots of the residuals, plots of residual vs fitted values, and the distribution of fitted Z-scores across gestational age. All models and goodness-of-fit assessments were fitted ajog.org 
Statistical analysis
Raw measurements for all biometric measures were recorded in millimeters. We analyzed the data in clinically relevant gestational age strata for 2 reasons: (1) identifying a gestational age threshold at which ZIKV-associated abnormal fetal growth is typically observed has clinical relevance; and (2) the effects of ZIKV infection on fetal growth are likely time-dependent with more significant effects occurring in later pregnancy. Gestational age strata were chosen to correspond to transitions classically associated with neonatal viability (18e24 weeks) and morbidity (late second trimester: 24e28 weeks, early third trimester: 28e34 weeks, and near term !34 weeks). The latest ultrasound per subject was analyzed in each gestational age strata. Wilcoxon signed rank test was used to compare distribution of paired Z-scores for HC to FL or AC to FL. Statistical significance was reported for P values <.05. Analysis was completed using software (STATA, Version 11.2, StataCorp LP).
Results
ZIKV diagnosis and timing of exposure
Study participants were pregnant women diagnosed with ZIKV infection after travel to countries with local transmission, who received obstetrical care from Columbia University Medical Center (New York, NY) from Jan. 1, 2016, through Feb. 1, 2017. A total of 66 pregnant women were retrospectively identified with a recent ZIKV infection and 56 were included based on availability of ultrasound data within the Columbia University health care system. The cohort was of mixed race/ ethnicity: 12 Hispanic/white, 7 Hispanic/black, 2 Hispanic/Pacific Islander, 3 white, and 32 other (unknown/>1 race). Thirteen women (13/56, 23%) recalled symptoms consistent with ZIKV infection including a rash, conjunctivitis, fever, and myalgias (Supplemental Table 4 ). ZIKV infection was diagnosed based on laboratory evidence for a confirmed ZIKV infection Table 6 ). In 3 pregnancies (3/52; 6%), a pregnancy termination was performed in the second trimester after a diagnosis of microcephaly. One stillbirth occurred at 30 weeks' gestation (1/52; 2%) in a microcephalic fetus with symmetric severe growth restriction. Of the remaining 48 pregnancies, term birth occurred in 92% (44/48) and preterm birth in 8% (4/48). A postnatal head ultrasound was performed in 39 cases and identified a grade-1 intraventricular hemorrhage (1/ 39, 3%) or choroid plexus cyst (4/39, 10%), but no other structural findings associated with the congenital ZIKV syndrome (Supplemental Table 6 ). Neonatal HC was measured in 47 of the 48 newborns with a mean Z-score of 0.4 using IG-21. At birth, microcephaly was observed in 1 neonate (HC Z-score e2) and no neonates had a HC Z-score e3 (Supplemental Table 6 ). Interpretation of the laboratory testing for ZIKV infection of the neonate is limited by the transient nature of the viremia, but results were available for 41 infants; a possible ZIKV infection was diagnosed in 39% of cases (16/41) (Supplemental Table 4 ) and 1 infant had a confirmed ZIKV infection (1/41, 2%).
Microcephaly and femur-sparing pattern of IUGR identified using single fetal biometric measures and fetal body ratios Next, we compared paired biometric measures from each subject to determine if maternal ZIKV infection was associated with differential growth of the HC or AC with respect to the FL. Overall, the AC was significantly smaller than FL based on the last ultrasound scan in pregnancy by either IG-21 or WHO-FGC (Table 2 and Supplemental  Table 7 ) (P < .001 for both analyses); this difference was also significant in every strata starting with the 24e27 6/7 week category for IG-21 and most strata for WHO-FGC. The HC was also significantly smaller than FL in the overall analysis by IG-21 (P < .001) and in every strata beginning with 28e33 6/7 weeks; this difference was not significant by WHO-FGC.
Another method to identify ZIKVassociated differential growth of the fetal head or abdomen with respect to the femur would involve an analysis of fetal body ratios (eg, HC:FL or AC:FL). To this end, we developed IG-21 fetal body ratios based on previously published data from 4607 normal pregnancies in 18 different countries. 20 These fetal body ratios were used to generate Z-scores in our cohort to compare differences in size of the fetal head and/or abdomen vs the femur. In contrast to a 5% rate of microcephaly, a femur-sparing pattern of fetal growth restriction was observed >34 weeks' gestation in 37% (17/46) of pregnancies based on either a small head (HC:FL; 28%, 13/46) or abdomen (AC:FL; 20%, 9/46) in relation to the femur (Z-scores <e1.3) (Figure 1 Figure 1) ; this final analysis allowed inclusion of fetuses from the second-trimester pregnancy terminations and the stillbirth and preterm birth cases. If we considered only women with symptomatic ZIKV infection, an abnormal HC:FL ratio was observed in 46% (6/13) and an abnormal AC:FL ratio in 15% (2/13). In pregnancies with an abnormal HC:FL or AC:FL ratio, the ratio became more skewed over time in most pregnancies (Supplemental Figures 1 and 2) . Overall, the majority of pregnancies in our study with a possible maternal ZIKV infection developed a femur-sparing profile of growth restriction using fetal body ratios developed from the IG-21 sonographic standard.
Comment
Principal findings of the study
Our study is the first to demonstrate a femur-sparing pattern of IUGR in late gestation of women with a possible ZIKV infection. This unusual fetal growth profile was found by application of the IG-21 and WHO-FGC standards and differs from prior models of IUGR (Figure 2 ). We found a significant skewing of fetal biometrics with a smaller AC vs FL, which was first apparent in the 24e27 6/7 week strata. Fetal body ratios (HC:FL and AC:FL, by IG-21) were consistent with a femursparing pattern of fetal growth restriction in the majority of pregnancies with possible maternal ZIKV infection. Values reflect mean (SD) of Z-scores within each gestational age strata using last ultrasound scan in each pregnancy or gestational age strata based on number of subjects.
P values were calculated using Wilcoxon rank sum to compare paired Z-scores (International Fetal and Newborn Growth Consortium for 21st Century Project) between FL and HC or FL and AC. Original Research OBSTETRICS ajog.org
Results in the context of what is known
Fetuses that were either small for gestational age or growth restricted were reported to occur in 9% of pregnancies with a possible ZIKV infection in Rio de Janeiro, Brazil. 2 Interestingly, the authors characterized 4 cases of microcephaly in their cohort as either "proportionate" (2/4, 50%) or "disproportionate" (2/4, 50%) relative to the size of the infant; a "disproportionate" microcephaly indicated a grossly differential growth of the head with respect to other body parts in at least half of their index cases. IUGR has also been described as a hallmark feature of several murine models of ZIKV infection in pregnancy and is associated with spontaneous abortion and stillbirth in these models. [39] [40] [41] [42] Although a femur-sparing pattern of growth restriction has been mentioned in the literature, 43 it has not been characterized in the context of maternal complications of pregnancy or exposure to any teratogenic virus. Interestingly, few studies have characterized the IUGR phenotype in pregnancies with viral infections with the exception of a symmetric profile of IUGR associated with congenital cytomegalovirus infection. 13 
Skewed distribution of fetal biometry in pregnancies with possible maternal ZIKV infection
Beginning in the late second trimester, maternal ZIKV infection was associated with a significantly smaller AC, by both IG-21 and WHO-FGC, and HC by IG-21 compared to FL. Analysis of IG-21 fetal body ratios with respect to FL revealed a femur-sparing profile of growth restriction in the majority of pregnancies with a possible ZIKV infection. The stable or negative trajectory of the AC:FL or HC:FL over time and the high proportion of women with symptoms (nearly half) with an abnormal HC:FL ratio is concerning for ZIKV-associated fetal injury. Identification of a femur-sparing profile of fetal growth restriction using IG-21 fetal body ratios could aid pediatricians in prioritizing neonates for imaging in low-resource settings. It is important to note that this profile of injury may not be obvious using other sonographic standards, primarily due to differences in FL distribution. For example, the Hadlock sonographic standard is anecdotally associated with the finding of "short femurs" and may not yield the same growth-restriction profile. [27] [28] [29] A discordance between the rate of fetuses with a small AC and rate of small-for-gestational-age neonates may be a consequence of this particular type of growth restriction that preserves skeletal growth, which may compensate for birthweight. Whether abnormal growth of the fetus in relation to the femur correlates with long-term adverse outcomes for the developing child is unknown, but identification of an abnormal fetal body ratio (AC:FL or HC:FL) may be superior to measurement of fetal BPD or HC alone as a marker for ZIKV-associated fetal injury.
Clinical and research implications
The pathogenesis of perinatal infections resulting in fetal injury is complex and involves both indirect and direct effects. ZIKV infections could have a direct effect on fetal growth through targeted injury of the brain and liver, but also an indirect effect through trophoblast injury and a reduction in oxygen carrying capacity. 43 If viral tropism for cells in the fetal brain and liver is greater than tropism for the skeleton, this could produce differential viral effects on fetal growth that might result in the femursparing profile of fetal growth restriction that we observed in our study. As the size of the fetal abdomen directly correlates with liver size, 44 ZIKV injury of the ajog.org
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fetal liver may depress growth of the abdomen. ZIKV RNA has been detected in the liver in human beings and animal models. 11, 45, 46 Liver injury is also a wellknown outcome for many viruses related to ZIKV (eg, hepatitis C, dengue virus). 47, 48 Future studies of the effect of ZIKV on the fetal liver may in part explain the pathogenesis of fetal growth restriction with this infection.
We would like to emphasize that our results do not suggest that a femursparing profile of growth restriction is the only possible phenotype or outcome of perinatal ZIKV infection. A normal growth profile may occur if the pregnant woman clears the virus before vertical transmission can occur. A fetal growth profile consistent with symmetric IUGR may occur with early and severe placental infections, which could compromise placental function; this effect would be similar to observations of placental infarctions and compromised placental oxygen transport in a nonhuman primate model following experimental ZIKV infection. 43 Additional research may further elucidate the relationship between IUGR and ZIKV infection, and characterize extreme cases of fetal injury, phenotype of IUGR and impact of timing of infection. Finding a more sensitive biomarker of viral injury, such as a sonographic profile of fetal growth, may help guide the pediatricians' evaluation and triage cases for postnatal follow-up where resources are limited.
Strengths and weaknesses
The strengths of this study are in the detailed fetal growth assessment from a relatively large sample of pregnancies with possible maternal ZIKV infection and the novel identification of a variant in fetal growth restriction associated with viral infection. A further strength is in the evaluation and comparison of biometric measures using 2 contemporary, international fetal growth studies. Finally, the novel use of IG-21 fetal body ratios to interpret fetal size in pregnancies with possible ZIKV infection may be useful for clinical care and also relevant to more common forms of IUGR. One limitation of our study is that the diagnosis of ZIKV infection is challenging due to the transient nature of viremia and cross-reactivity with other flaviviruses. Another important study limitation is the small sample size and lack of a specific fetal growth standard for this population; creating a robust standard would be challenging, however, given the ethnic diversity of the cohort. Future studies with larger cohorts are necessary to validate our findings and determine if adverse neonatal outcomes might be associated with a femur-sparing profile of growth restriction. Although our study definitions of IUGR and microcephaly were in line with current standards, they may capture some constitutionally small infants; as we did not base IUGR on EFW, this may also limit comparability to other studies. However, the surprising distribution of cases with differential growth of the abdomen and head vs the femur is suggestive of an unusual pattern of fetal growth restriction that is not typically seen in pregnancy.
Conclusion
In summary, our results suggest that infants born following a possible maternal ZIKV infection may have abnormal growth patterns of the fetal head and abdomen with respect to the femur. Calculation of IG-21 fetal body ratios (AC:FL or HC:FL) may provide an early indication of aberrant fetal growth before a clinical or sonographic diagnosis of IUGR or microcephaly. Alerting clinicians to deviations in symmetric growth of a nonmicrocephalic fetus with congenital ZIKV exposure may aid in the identification of cases at risk for a greater spectrum of ZIKV-associated morbidity (eg, eye abnormalities, postnatal microcephaly). These cases could be prioritized for more intensive neonatal follow-up in low-resource settings for earlier interventions after delivery. Ultimately, larger cohorts will be important to validate a femur-sparing profile of growth restriction in women with a possible ZIKV infection in pregnancy and investigate whether this profile might predict adverse fetal and neonatal outcomes. n Values for biparietal diameter:femur length (mean and SD) derived from International Fetal and Newborn Growth Consortium for 21st Century Project Values reflect mean percentile (SD) within each gestational age strata using last ultrasound scan in each pregnancy or gestational age strata based on number of subjects.
P values were calculated using Wilcoxon rank sum to compare percentiles determined by World Health Organization Fetal Growth Chart study between HC and FL or AC and FL. P value of <.05 was considered significant. Original Research OBSTETRICS ajog.org
